Group 1 - The core viewpoint emphasizes the importance of on-site inspections by regulatory authorities as a key measure to ensure the quality of IPO companies and prevent fraudulent activities in the capital market [1][2] - As of the end of 2025, 16 randomly selected companies did not withdraw their IPO applications, with 7 companies having passed the listing committee review, indicating a significant improvement in the IPO ecosystem [1] - On-site inspections are a regulatory enforcement tool granted to the China Securities Regulatory Commission (CSRC), complementing written reviews of IPO applications [1] Group 2 - On-site inspections are essential for strengthening the entire IPO regulatory chain, ensuring the quality of IPO companies, and fostering a positive environment where fraudulent activities are discouraged [2] - The inspections have effectively eliminated the "pass-through mentality" among companies, promoting compliance as a fundamental aspect of their operations [2] - Challenges remain in the on-site inspection process, necessitating a more scientific approach to coverage and effectiveness, with a focus on high-risk industries and the use of technology to enhance regulatory capabilities [2] Group 3 - The healthy development of the capital market begins with stringent entry standards and is sustained through regulatory norms [3] - On-site inspections are viewed as a new starting point for regulating corporate development and purifying the market environment, with expectations for continued effectiveness in promoting high-quality development in the capital market [3]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has reported improvements in the quality of IPO applications, with a significant reduction in market irregularities such as "withdrawal upon inspection" [1][2] Group 1: Inspection Overview - In 2022, the CSRC completed inspections of 16 randomly selected IPO applicants and 4 problem-oriented enterprises, indicating a systematic approach to enhancing application quality [1] - The CSRC has implemented regular random and problem-oriented inspections for new IPO applicants, with 20% of new applications being randomly selected for quality verification [1][2] Group 2: Findings from Inspections - Among the inspected enterprises, 2 were found to have serious violations related to information disclosure, including inflating revenue through fictitious business activities, leading to strict accountability measures for both issuers and intermediaries [2] - 6 enterprises exhibited deficiencies in information disclosure quality, resulting in varying levels of regulatory responses, including public criticism and warnings based on the severity of the issues [2] - 12 enterprises were identified with normative flaws in information disclosure, which did not affect the review process, prompting the CSRC to require corrective actions without imposing regulatory penalties [2] Group 3: Future Directions - The CSRC aims to enhance the effectiveness and coverage of inspections, focusing on risk-oriented approaches and prioritizing key issues to continuously improve the quality of IPO applications and protect investor rights [2]

Core Viewpoint - The article highlights significant improvements in the IPO inspection process, with a notable reduction in the "one check and withdraw" phenomenon among companies applying for IPOs in the past year [2]. Group 1: IPO Inspection Results - In 2025, the China Securities Regulatory Commission (CSRC) completed inspections of 16 randomly selected and 4 problem-oriented IPO candidates, involving 8 companies from the main board, 9 from the Sci-Tech Innovation Board, and 3 from the Growth Enterprise Market [2]. - The CSRC reported that all 16 randomly selected companies did not withdraw their listing applications, with 7 having passed the exchange's listing committee review [3]. Group 2: Issues Identified - Among the 20 companies inspected, 2 were suspected of major violations in information disclosure, 6 had deficiencies in disclosure quality, and 12 had normative flaws in their disclosures [4]. - Specific issues included inflated revenue through fictitious business activities, improper accounting treatments, and omissions in disclosing significant related-party transactions [4]. Group 3: Future Directions - The CSRC plans to further enhance the effectiveness and coverage of IPO inspections, focusing on risk orientation, prioritizing key areas, and classifying issues to continuously improve the quality of applications from prospective listed companies [5].

Group 1 - The core viewpoint of the news is that the China Securities Regulatory Commission (CSRC) has conducted inspections on IPO applications, resulting in improved application quality and a focus on risk prevention and regulatory effectiveness [1][2][3] Group 2 - In 2025, the CSRC completed inspections on 20 companies, including 16 randomly selected and 4 targeted for issues, with 8 from the main board, 9 from the Sci-Tech Innovation Board, and 3 from the Growth Enterprise Market [1] - All 16 randomly selected companies did not withdraw their IPO applications, and 7 have passed the exchange's listing committee review [1][3] - The CSRC emphasizes the importance of maintaining a balance between investor protection and regulatory inclusiveness while preventing oversimplification in inspection processes [2] Group 3 - Two companies were found to be suspected of major violations in information disclosure, including inflating revenue through fictitious business activities [4] - Six companies exhibited deficiencies in information disclosure quality, leading to varying degrees of regulatory responses, including public criticism and warnings [4] - Twelve companies had normative flaws in information disclosure that did not affect the review process, prompting the CSRC to urge rectification without imposing regulatory measures [4]

Group 1 - The core viewpoint of the news is that the China Securities Regulatory Commission (CSRC) has reported improvements in the IPO inspection process, with a significant reduction in the "one check and withdraw" phenomenon among companies applying for IPOs in 2025 [1] - In the past year, the CSRC completed inspections of 16 randomly selected companies and 4 problem-oriented companies, involving 8 from the main board, 9 from the Sci-Tech Innovation Board, and 3 from the Growth Enterprise Market [1] - The CSRC stated that the quality of applications from newly accepted IPO companies has improved, with clearer understanding and expectations from market participants regarding the inspection process [1] Group 2 - Among the 20 companies inspected, 2 were suspected of major violations in information disclosure, 6 had deficiencies in information disclosure quality, and 12 had normative flaws in information disclosure [2] - Issues identified included inflated revenue through fictitious business activities, improper accounting treatments, and omissions in disclosures related to controlling shareholders or important related parties [2] - The CSRC plans to further enhance the coverage and effectiveness of inspections, focusing on risk-oriented approaches and improving the quality of applications from prospective listed companies [2]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has reported improvements in the quality of IPO applications, with 16 randomly selected companies not withdrawing their applications by the end of 2025, and 7 of them passing the listing committee review [1]. Group 1: Inspection Overview - The CSRC conducted inspections on 16 randomly selected new applicants, representing a 20% sampling rate, to verify the quality of their applications [2]. - The inspections emphasized the principle of importance to avoid a one-size-fits-all approach, with regulatory measures tailored to the nature of the issues identified [2]. - Four companies were subject to problem-oriented inspections due to significant doubts regarding their compliance with listing conditions [2]. Group 2: Issues Identified - Among the 20 companies inspected, two were found to have serious violations of information disclosure, including inflating revenue through fictitious business activities [3]. - Six companies exhibited deficiencies in information disclosure quality, such as improper accounting practices and failure to disclose important related-party transactions [3]. - Twelve companies had normative flaws in their disclosures, which did not affect the review process, leading to corrective actions rather than regulatory penalties [3]. Group 3: Future Directions - The CSRC plans to enhance the effectiveness and coverage of inspections, maintaining a risk-oriented approach while focusing on key issues and categorizing responses [3].

Core Viewpoint - The China Securities Regulatory Commission (CSRC) emphasizes the importance of on-site inspections for IPO applicants as a key part of the regulatory framework to enhance the quality of applications and promote high-quality development in the capital market [1] Group 1: Overall Inspection Situation - The CSRC conducts regular on-site inspections through random selection and problem-oriented approaches, with a 20% random sampling rate for newly accepted enterprises to verify application quality [2] - The inspections have led to an improvement in the quality of applications, with all 16 randomly selected enterprises not withdrawing their IPO applications by the end of 2025, and 7 of them passing the exchange's listing committee review [2] - The market's understanding of the inspection process has improved, reducing chaotic behaviors such as "withdraw upon inspection" [2] Group 2: Issues Found and Handling - Two enterprises were found to have significant violations in information disclosure, including inflating revenue through fictitious business activities, leading to investigations and potential severe penalties for responsible parties [3] - Six enterprises exhibited defects in information disclosure quality, resulting in two receiving public criticism and four being warned, with corresponding measures taken against intermediary institutions based on their performance [3] - Twelve enterprises had normative flaws in information disclosure that did not affect the review process, prompting the CSRC to require rectification without imposing regulatory measures [3] - The CSRC aims to enhance the effectiveness of inspections while maintaining a risk-oriented approach, focusing on key issues and categorizing responses to improve the quality of applications and protect investor rights [3]

Core Insights - A new round of IPO现场检查 (on-site inspections) has commenced at the beginning of 2026, with 11 companies selected for inspection [2][12]. Group 1: IPO Inspection Details - The first batch of companies for the 2026 IPO现场检查 includes 11 firms, with 6 from the 科创板 (Sci-Tech Innovation Board), 4 from the 创业板 (ChiNext), and 1 from the 上证主板 (Shanghai Stock Exchange Main Board) [2][12]. - The number of IPO projects accepted in the fourth quarter of 2025 reached 49, a significant increase compared to 2024, indicating a recovery in the A-share IPO market [2][12]. - The ratio of companies selected for on-site inspections aligns with the acceptance rate of new IPO applications, with a target coverage of at least one-third for new applications [3][13]. Group 2: Company Profiles - The selected companies span various sectors, including semiconductors, medical devices, commercial aerospace, and artificial intelligence, with four currently operating at a loss [4][14]. - 蓝箭航天 (Blue Arrow Aerospace) is notable as the first commercial rocket company to be accepted under the new listing standards, with a pre-IPO valuation of 20.7 billion yuan [4][14]. - 汉诺医疗 (Hanno Medical) is the first domestic company to achieve the localization of ECMO systems, while 锐石创芯 (Rui Shi Chuang Xin) focuses on RF chip manufacturing, with significant R&D investments [4][14][15]. - 粤芯半导体 (Yuexin Semiconductor) is the first 12-inch wafer manufacturer in Guangdong, with a post-investment valuation of 25.3 billion yuan and consistent revenue above 1 billion yuan [5][15]. Group 3: Financial Metrics - The total fundraising target for the 11 companies is 26.22 billion yuan, with 蓝箭航天 and 粤芯半导体 each aiming to raise 7.5 billion yuan [5][15]. - 中盐股份 (Zhongyan Co.) is the largest in terms of revenue and profit, with 2024 revenues of 7.044 billion yuan and a net profit of 692 million yuan [5][15]. Group 4: Regulatory Environment - The trend of "一查就撤" (withdrawal upon inspection) has improved, with no companies withdrawing from inspections in 2025, contrasting with high withdrawal rates in previous years [8][18]. - Regulatory measures have been implemented to enhance accountability among investment banks and companies, aiming to improve the quality of listed companies [19][20].

Core Insights - A new round of IPO现场检查 has begun in early 2026, with 11 companies selected for on-site inspections, primarily from the 科创板 and 创业板 sectors [2][5]. Group 1: IPO Inspection Details - The first batch of companies for现场检查 includes 6 from the 科创板, 4 from the 创业板, and 1 from the 上证主板, indicating a significant focus on technology and innovation [2][4]. - The number of companies accepted for IPOs has increased significantly, with 49 projects accepted in the fourth quarter of 2025, a notable rise compared to 2024 [2][3]. - The ratio of companies selected for现场检查 aligns with the acceptance rate, with a target of at least 1/3 of new applications undergoing inspections [3][8]. Group 2: Company Performance and Financials - Among the 11 selected companies, four are currently operating at a loss, including 蓝箭航天 and 汉诺医疗, which have significant negative net profits over recent years [5][6]. - 蓝箭航天, a commercial rocket company, has a pre-IPO valuation of 207 billion, with net profits of -8.04 billion in 2022 and -5.97 billion in the first half of 2025 [5][6]. - 汉诺医疗, specializing in medical devices, reported net losses of -6478.83 million in 2022 and -8227.32 million in the first half of 2025 [5][6]. Group 3: Fundraising and Market Trends - The total fundraising target for the 11 companies is 262.20 billion, with 蓝箭航天 and 粤芯半导体 each aiming to raise 75 billion [7]. - 中盐股份, the largest in terms of revenue, reported 2024 revenues of 70.44 billion and a net profit of 6.92 billion [7]. - The average net profit of the remaining seven companies is 1.69 billion, with average revenues of 20.13 billion [7]. Group 4: Regulatory Environment and Trends - The termination rate for IPO现场检查 has significantly decreased, with only 6.25% of companies withdrawing their applications in 2025, compared to much higher rates in previous years [8][10]. - Regulatory measures have been implemented to enhance the quality of IPO applications, including stricter oversight and accountability for both companies and intermediaries [10][11]. - The focus on compliance and thorough inspections is expected to increase the costs and complexity of the IPO process for companies [11].

Core Insights - The China Securities Association released the first batch of IPO companies for on-site inspection in 2026, including 11 firms such as Blue Arrow Aerospace and Frequency Precision Laser, with half of them coming from the Sci-Tech Innovation Board [1][3] Group 1: IPO Companies and Their Status - Among the 11 companies, only three—Yuexin Semiconductor, Luozhou Co., and Frequency Precision Laser—have entered the inquiry stage, while the remaining eight are still in the "accepted" phase [3] - The majority of companies targeting the Sci-Tech Innovation Board are six, including Blue Arrow Aerospace and Frequency Precision Laser, while four companies are aiming for the Growth Enterprise Market (GEM) and only one for the Shanghai Main Board [3] Group 2: Fundraising and Financial Performance - Blue Arrow Aerospace and Yuexin Semiconductor are both seeking to raise 7.5 billion yuan, despite being in a loss position during the reporting period [3][4] - Yuexin Semiconductor reported revenues of approximately 1.545 billion yuan, 1.044 billion yuan, 1.681 billion yuan, and 1.053 billion yuan for the years 2022 to 2025 H1, with corresponding net losses of about 1.043 billion yuan, 1.917 billion yuan, 2.253 billion yuan, and 1.201 billion yuan [4] - Other companies, including Luozhou Co. and Zhongyan Co., are looking to raise between 1 billion and 2 billion yuan, while companies like Lianqi Intelligent and Ruishi Chuangxin aim to raise less than 1 billion yuan [4] Group 3: Regulatory Context - The on-site inspection of IPO companies is a regulatory enforcement measure under the Securities Law, playing a crucial role in the overall IPO supervision process [4] - In 2025, the China Securities Association published three batches of on-site inspection lists, involving a total of 16 IPO companies, with a noticeable decrease in withdrawal rates compared to previous years [4]